You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 1 to 25 of about 6035
Next 25
06/08/2026
Researchers Uncover How an Aggressive Brain Tumor Evades Treatment
Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma
06/01/2026
Implanted Tile-Based Radiation Outperforms Stereotactic Radiotherapy for Treatment of Brain Metastases
Localized Synergistic Nanofibers Could Eliminate Glioblastoma
Chapter 132: Why can’t she just get over it?
More news from ASCO 2026
Research Spotlight: External Controls Show Promise for Use in Glioblastoma Clinical Trials
Copayment assistance program is now open!
05/18/2026
Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT Recurrent Glioblastoma Trial
Horizons in Neuro-oncology Webinar this week
Personalized vaccine shows promise against aggressive brain cancer
05/11/2026
NIH-funded study suggests that testosterone suppresses brain tumor growth in males
05/10/2026
Webinar tomorrow!
The Scientist Designing a Tailored Attack on Glioblastoma
05/04/2026
Webinar next week!
04/27/2026
Brown Health researchers identify key molecule behind `exceptional responders` with glioblastoma
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial
5th Annual Tumor Takedown Event in Florida!
04/20/2026
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma
04/13/2026
Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
Wearable Technology`s Growing Role in Monitoring Brain Health
Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved survival in preclinical glioblastoma models
GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial